1. Adlercreutz H, Martin F, Järvenpää P, Fotsis T (1979) Steroid absorption and enterohepatic recycling. Contraception 2:201?223
2. Bartsch H-H, Bastert G, Blossey HC, Douwes FR, Firusian N, Hauswaldt C, Illiger HJ, Johanning U, Kleeberg UR, Nagel GA, Schierle U, Schreml W, Wander HE (to be published) AIO-Studie M 1/79: Mitomycin C and high dose medroxyprogesteronacetate in the treatment of advanced breast cancer. Verhandlungen der deutschen Krebsgesellschaft
3. Besch PK, Vorys H, Ullery JC, Barry RD, Couri D (1966) In vivo metabolism of H3-medroxyprogesterone acetate in pregnant and nonpregnant women and in the fetus. Am J Obstet Gynecol 95:228?238
4. Blossey HC, Bartsch HH, Köbberling J (1980) Binding characteristics of medroxyprogesterone acetate to steroid receptors in human mamma carcinoma. J Clin Chem Clin Biochem 18:729?730
5. Blossey HC, Bartsch HH, Köbberling J (1981) Die mögliche klinische Bedeutung des Androgenrezeptors in Mammacarcinomen. In: Maas H, Jonat W (eds) Steroidhormonrezeptoren im Carcinomgewebe. F. Enke Verlag